EventsThe 1st International Online Conference on Gels
Published
This submission belongs to the session S2. Hydrogels, Organogels, Xerogels, and Aerogels of the event The 1st International Online Conference on Gels
Published date
28 Nov, 2025
Academic Editor
author-avatarSIDI A. BENCHERIF
Citation
Arjan Atwal, Ali Mahnavi, Pooya Davoodi, Nicholas R Forsyth, Martyn Snow, Design and Development of an Injectable Hydrogel for Cartilage Repair, in Proceedings of The 1st International Online Conference on Gels, 3 December–5 December 2025, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Design and Development of an Injectable Hydrogel for Cartilage Repair

Martyn Snow 3
image
image
1. Guy Hilton Research Centre, Keele University, Staffordshire, ST4 7QB, UK, UK
2. School of Allied Health Professions and Pharmacy, Keele University, Staffordshire, ST5 5BG, UK
3. Department of Arthroscopy, Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham, B31 2AP, UK, UK
4. Vice Principals’ Office, University of Aberdeen, Kings College, Aberdeen, AB24 3FX, UK, UK
Abstract

Articular cartilage injuries present a significant clinical challenge due to the tissue's limited intrinsic capacity for self-repair. Without effective treatment, such defects progress to osteoarthritis, severely impacting the patient’s mobility and quality of life. Existing clinical strategies, including microfracture and autologous chondrocyte implantation (ACI), are often associated with complications such as fibrocartilage formation and donor site morbidity. Injectable hydrogels offer a minimally invasive strategy with defect-conforming properties with the ability to deliver bioactive cues, yet conventional bulk ‘filler’ hydrogels are hindered by nanoporosity that limits nutrient transport and cell migration.

To overcome these limitations, a granular injectable hydrogel system was developed, composed of microparticles assembled from fragmented bulk hydrogels, thereby introducing interstitial microporosity to enhance cellular interactions and tissue integration. The hydrogel formulation was composed of gelatin methacryloyl-, hyaluronic acid methacryloyl-, and methacryloyl-modified platelet lysate. Bulk formulations were first optimized through live/dead viability assays, DNA and glycosaminoglycan quantification, and immunofluorescent staining for hyaline cartilage-specific markers. Granular hydrogels were fabricated by extruding and fragmenting the optimized bulk gels into microparticles, followed by centrifugation and photoannealing (λ=365nm). These constructs were evaluated using the same in vitro assays and further tested in an ex vivo osteochondral defect model.

Fabrication yielded large and small microparticles of 230 ± 82 µm and 46 ± 18 µm, respectively, with interstitial porosity ranging from 3–11% depending on centrifugation speed. While the optimized bulk hydrogel supported chondrocyte viability (+90%) and hyaline-like matrix production, granular hydrogels substantially improved repair outcomes. By day 31, GAG/DNA ratios reached 0.79 and 0.72 for small particle and large particle groups, compared to 0.677 for bulk gels. We report enhanced microporosity facilitated cell infiltration, more extracellular matrix deposition, and better integration with host cartilage. Immunostaining confirmed that the regenerated tissue was rich in type II collagen and aggrecan, resembling native hyaline cartilage.

Keywords
Granular Hydrogel
Cartilage repair
Osteoarthritis
Injectable
Prospects for the Rapid Delivery of Active Pharmaceutical Ingredients to the Brain for Neuroprotective Action: Examples of Nasal Gel Formulations
Multifunctional ADA-GEL hydrogels reinforced with iron-loaded dendritic bioactive glass nanoparticles for bone regeneration